Registration Successful

Thank you for signing up to the Anaphylaxis UK Business Newsletter! Keep an eye on your inbox each month for the need-to-know updates for your business.

The latest news and updates from Anaphylaxis UK

Research opportunity: have you had a severe food allergy since childhood that requires use of an adrenaline auto-injector? 14th February 2025

The University of Manchester is inviting individuals to participate in an event where they can share their healthcare experiences and contribute to meaningful discussions with student researchers. This research opportunity aims to help students learn directly from patients about their
[…]

Read more
Managing house dust mite allergy: treatment option now available on the NHS  12th February 2025

The National Institute for Health and Care Excellence (NICE) has released its final draft guidance, recommending Acarizax for NHS use in the management of house dust mite allergy. Developed by ALK-Abello, Acarizax is the first therapy specifically designed to treat
[…]

Read more
Needle-free nasal adrenaline treatment under review for approval in Canada and the UK 7th February 2025

ARS Pharmaceuticals has made significant progress in expanding access to neffy®, its needle-free adrenaline (epinephrine) nasal spray. After gaining approval in the U.S. and Europe for treating severe allergic reactions like anaphylaxis, ARS Pharmaceuticals has now filed for approval in
[…]

Read more

Find out more about anaphylaxis

Learn more